Mirae Asset Global Etfs Holdings Ltd. Tenaya Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 30,292 shares of TNYA stock, worth $30,292. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,292
Previous 22,778
32.99%
Holding current value
$30,292
Previous $70,000
17.14%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TNYA
# of Institutions
94Shares Held
56.4MCall Options Held
900Put Options Held
400-
Column Group LLC San Francisco, CA9.4MShares$9.4 Million26.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.98MShares$6.98 Million0.19% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$6.73 Million1.01% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$4.07 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$3.21 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $41.4M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...